BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34527048)

  • 41. Comparison of pituitary-adrenal responsiveness between insulin tolerance test and growth hormone-releasing peptide-2 test: a pilot study.
    Kano T; Sugihara H; Sudo M; Nagao M; Harada T; Ishizaki A; Nakajima Y; Tanimura K; Okajima F; Tamura H; Ishii S; Shibasaki T; Oikawa S
    Peptides; 2010 Apr; 31(4):657-61. PubMed ID: 20045717
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rapid decrease in adrenal responsiveness to ACTH stimulation after successful pituitary surgery in patients with Cushing's disease.
    Alwani RA; de Herder WW; de Jong FH; Lamberts SW; van der Lely AJ; Feelders RA
    Clin Endocrinol (Oxf); 2011 Nov; 75(5):602-7. PubMed ID: 21623858
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Earlier post-operative hypocortisolemia may predict durable remission from Cushing's disease.
    Ironside N; Chatain G; Asuzu D; Benzo S; Lodish M; Sharma S; Nieman L; Stratakis CA; Lonser RR; Chittiboina P
    Eur J Endocrinol; 2018 Mar; 178(3):255-263. PubMed ID: 29330227
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Which patients benefit from provocative adrenal testing after transsphenoidal pituitary surgery?
    Auchus RJ; Shewbridge RK; Shepherd MD
    Clin Endocrinol (Oxf); 1997 Jan; 46(1):21-7. PubMed ID: 9059554
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic value of standard deviation score of log-transformed serum dehydroepiandrosterone sulfate in patients with hypothalamic-pituitary-adrenal axis insufficiency.
    Edo N; Morita K; Ishiwata C; Nakajima R; Sayama Y; Suzuki T; Sakamoto M; Okamoto K; Uchino T; Ozawa Y; Uno K; Uno K; Tsukamoto K; Ishikawa T
    Endocr J; 2021 Nov; 68(11):1337-1345. PubMed ID: 34162776
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-acting intramuscular ACTH stimulation test for the diagnosis of secondary adrenal insufficiency in children.
    Sharma R; Madathil S; Maheshwari V; Roy K; Kumar B; Jain V
    J Pediatr Endocrinol Metab; 2019 Jan; 32(1):57-63. PubMed ID: 30530907
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Desmopressin Test Predicts Better Than Basal Cortisol the Long-Term Surgical Outcome of Cushing's Disease.
    Vassiliadi DA; Balomenaki M; Asimakopoulou A; Botoula E; Tzanela M; Tsagarakis S
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4878-4885. PubMed ID: 27662440
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low Diagnostic Utility of Overnight High-Dose Dexamethasone Suppression Test in ACTH-Dependent Cushing's Syndrome.
    Kumar A; Kanwar J; Bharti N; Agrawal V; Bhatia E; Yadav SC
    Endocr Pract; 2021 Jul; 27(7):723-727. PubMed ID: 34250909
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alterations in hypothalamic-pituitary-adrenal function immediately after resection of adrenal adenomas in patients with Cushing's syndrome and others with incidentalomas and subclinical hypercortisolism.
    Khawandanah D; ElAsmar N; Arafah BM
    Endocrine; 2019 Jan; 63(1):140-148. PubMed ID: 30259310
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SERUM FREE CORTISOL DURING GLUCAGON STIMULATION TEST IN HEALTHY SHORT-STATURED CHILDREN AND ADOLESCENTS.
    Weintrob N; Davidov AS; Becker AS; Israeli G; Oren A; Eyal O
    Endocr Pract; 2018 Mar; 24(3):288-293. PubMed ID: 29547045
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Low- and standard-dose corticotropin and insulin hypoglycemia testing in the assessment of hypothalamic-pituitary-adrenal function after pituitary surgery.
    Courtney CH; McAllister AS; Bell PM; McCance DR; Leslie H; Sheridan B; Atkinson AB
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1712-7. PubMed ID: 15070935
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Progressive dysregulation of autonomic and HPA axis functions in HIV-1 clade C infection in South India.
    Chittiprol S; Kumar AM; Satishchandra P; Taranath Shetty K; Bhimasena Rao RS; Subbakrishna DK; Philip M; Satish KS; Ravi Kumar H; Kumar M
    Psychoneuroendocrinology; 2008 Jan; 33(1):30-40. PubMed ID: 17993249
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evidence of hypothalamic-pituitary-adrenal axis suppression during moderate-to-high-dose inhaled corticosteroid use.
    Cavkaytar O; Vuralli D; Arik Yilmaz E; Buyuktiryaki B; Soyer O; Sahiner UM; Kandemir N; Sekerel BE
    Eur J Pediatr; 2015 Nov; 174(11):1421-31. PubMed ID: 26255048
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DIAGNOSTIC ACCURACY OF BASAL CORTISOL LEVEL TO PREDICT ADRENAL INSUFFICIENCY IN COSYNTROPIN TESTING: RESULTS FROM AN OBSERVATIONAL COHORT STUDY WITH 804 PATIENTS.
    Struja T; Briner L; Meier A; Kutz A; Mundwiler E; Huber A; Mueller B; Bernasconi L; Schuetz P
    Endocr Pract; 2017 Aug; 23(8):949-961. PubMed ID: 28614010
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immediate postoperative cortisol levels accurately predict postoperative hypothalamic-pituitary-adrenal axis function after transsphenoidal surgery for pituitary tumors.
    Marko NF; Hamrahian AH; Weil RJ
    Pituitary; 2010 Sep; 13(3):249-55. PubMed ID: 20339931
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Postoperative plasma cortisol levels predict long-term outcome in patients with Cushing's disease and determine which patients should be treated with pituitary irradiation after surgery.
    Imaki T; Tsushima T; Hizuka N; Odagiri E; Murata Y; Suda T; Takano K
    Endocr J; 2001 Feb; 48(1):53-62. PubMed ID: 11403103
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prospective evaluation of a week one overnight metyrapone test with subsequent dynamic assessments of hypothalamic-pituitary-adrenal axis function after pituitary surgery.
    English K; Inder WJ; Weedon Z; Dimeski G; Sorbello J; Russell AW; Duncan EL; Cuneo R
    Clin Endocrinol (Oxf); 2017 Jul; 87(1):35-43. PubMed ID: 28329436
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Delayed peak response of cortisol to insulin tolerance test in patients with Prader-Willi syndrome.
    Oto Y; Matsubara K; Ayabe T; Shiraishi M; Murakami N; Ihara H; Matsubara T; Nagai T
    Am J Med Genet A; 2018 Jun; 176(6):1369-1374. PubMed ID: 29696788
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DHEA(S)--a novel marker in Cushing's disease.
    Burkhardt T; Schmidt NO; Vettorazzi E; Aberle J; Mengel M; Flitsch J
    Acta Neurochir (Wien); 2013 Mar; 155(3):479-84; discussion 484. PubMed ID: 23314986
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Negative surgical exploration in patients with Cushing's disease: benefit of two-thirds gland resection on remission rate and a review of the literature.
    Carr SB; Kleinschmidt-DeMasters BK; Kerr JM; Kiseljak-Vassiliades K; Wierman ME; Lillehei KO
    J Neurosurg; 2018 Nov; 129(5):1260-1267. PubMed ID: 29219752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.